Eternity Bioscience Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Eternity Bioscience Inc..The latest application filed is for "azole compounds as irak inhibitors, preparation methods and medicinal uses thereof".

Company Profile

0.4.18

Eternity Bioscience Inc. - Cranbury NJ US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Azole Compounds As Irak Inhibitors, Preparation Methods And Medicinal Uses Thereof App 20220213086 - Li; Hongbin ; et al.	2022-07-07
Alkyne Compounds As Irak Inhibitors, Preparation Methods And Medicinal Uses Thereof App 20220177446 - Li; Hongbin ; et al.	2022-06-09
Compounds As Bruton Tyrosine Kinase Inhibitors, Preparation Methods And Medical Applications Thereof App 20220169645 - Li; Puhui ; et al.	2022-06-02
Irak Inhibitors, Preparation Method And Medicinal Uses Thereof App 20220144842 - Li; Hongbin ; et al.	2022-05-12
Biaryl Amide Compounds, Preparation Methods And Medical Applications Thereof App 20220135539 - Zhao; Peng ; et al.	2022-05-05
Adamts Inhibitors, Preparation Methods And Medicinal Uses Thereof App 20220009909 - Liu; Dong ; et al.	2022-01-13
Tyrosine Kinase 2 Inhibitors, Preparation Methods And Medicinal Uses Thereof App 20220009910 - Zhuang; Linghang ; et al.	2022-01-13
Tyrosine Kinase 2 Inhibitors, Preparation Methods And Medicinal Uses Thereof App 20220002267 - Zhuang; Linghang ; et al.	2022-01-06
Substituted ethynyl heterobicyclic compounds as tyrosine kinase inhibitors Grant 10,144,737 - Zhang , et al. De	2018-12-04
Aminopyridazinone compounds as protein kinase inhibitors Grant 9,951,077 - Liu , et al. April 24, 2	2018-04-24
Aminopyridazinone Compounds As Protein Kinase Inhibitors App 20170152264 - LIU; Dong ; et al.	2017-06-01
Substituted Ethynyl Heterobicyclic Compounds As Tyrosine Kinase Inhibitors App 20170114063 - Zhang; Minsheng ; et al.	2017-04-27
Furanone compounds as kinase inhibitors Grant 9,458,140 - Liu , et al. October 4, 2	2016-10-04
Aminoisoquinoline Derivatives as Protein Kinase Inhibitors App 20160257676 - Zhang; Minsheng ; et al.	2016-09-08
Furanone Compounds as Kinase Inhibitors App 20160096825 - Liu; Dong ; et al.	2016-04-07
Quinazolinediones And Their Use App 20140031358 - Liu; Dong ; et al.	2014-01-30
Phosphorus Containing Compounds As Protein Kinase Inhibitors App 20120220551 - Hu; Baihua ; et al.	2012-08-30

Company Registrations

NCAGE Code	7WFN5	ETERNITY BIOSCIENCE INC
CAGE Code	7WFN5	ETERNITY BIOSCIENCE INC
S.A.M. Registration	7WFN5 [962036583]	ETERNITY BIOSCIENCE INC
DUNS	962036583	Eternity Bioscience Inc

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.